1. Intravenous Streptokinase in Acute Myocardial Infarction Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity, and infarct size at 21 days;N Engl J Med,1986
2. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian study of early thrombolysis (ASSET);Wilcox, R.G.; Olsson, C.G.; Skene, A.M.; van der Lippe, G.; Jenson, G.; Hampton, JR;Lancei,1988
3. Electrocardiographs in general practice. Br MedJ3;Davies, A.,1989